Scheme 3.
Increasing the kinase specificity of the kinase inhibitor K252a through conjugation of K252a to a miniature protein that features the cAMP-dependent protein kinase (PKA) recognition epitope. Reproduced and edited with permission from Schneider et al. (2005).